Oklahoma judge reduces Johnson & Johnson order in opioid lawsuit by $107M

News
Prescription medication

close up of a hand handling prescriptions pills as a concept

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

OKLAHOMA CITY (AP) – An Oklahoma judge who last summer ordered consumer products giant Johnson & Johnson to pay $572 million to help address the state’s opioid crisis is reducing that amount by $107 million in his final order in the case.

District Judge Thad Balkman on Friday issued the order directing the company to pay the state $465 million, acknowledging that he miscalculated in his original award how much it would cost to develop a program for treating babies born addicted to opioids. The cost should have been $107,000, not $107 million.

The judge declined a request by the defendants to further reduce the amount to take into account pre-trial settlements totaling $355 million the state reached with Oxycontin-maker Purdue Pharma and Israeli-owned Teva Pharmaceuticals.

Attorneys for Johnson & Johnson say the company plans to appeal.

Latest News

More News

National News

More National

Washington D.C.

More Washington DC

Your Local Election HQ

More Your Local Election HQ
graphic of the Red Cross

Latest News

More News

Popular

KFOR Podcasts

More Podcasts

Follow @KFOR on Twitter